Lexaria Bioscience (LEXX) Total Debt Growth (1y) (2012 - 2022)
Lexaria Bioscience (LEXX) Total Debt Growth (1y) (2012 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.63 Mn |
2.11 Mn |
20,000.00 |
- |
| Date | Value |
|---|
| May 31, 2022 |
497.13% |
| Nov 30, 2021 |
-93.38% |
| Aug 31, 2021 |
-74.16% |
| May 31, 2021 |
-97.73% |
| Feb 28, 2021 |
12,825.38% |
| Nov 30, 2020 |
217.30% |
| Aug 31, 2020 |
-36.23% |
| May 31, 2020 |
177.93% |
| Feb 29, 2020 |
-71.54% |
| Nov 30, 2019 |
71.79% |
| Aug 31, 2019 |
512.30% |
| May 31, 2019 |
130.46% |
| Feb 28, 2019 |
0.48% |
| Nov 30, 2018 |
-13.45% |
| Aug 31, 2018 |
-81.60% |
| May 31, 2018 |
22.35% |
| Feb 28, 2018 |
-98.02% |
| Nov 30, 2017 |
-93.30% |
| Aug 31, 2017 |
-87.12% |
| May 31, 2017 |
-97.10% |
